// App-Quantinova.ai

TCT-583 : Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent: The PROMUS Element Plus US Post-Approval Study

Researchers

Presenter

  • David Kandzari

Principal Investigators

  • Nima Amjadi Nima Amjadi

  • Christopher Caputo

  • Steven Rowe

  • Henry Chen

  • Jerome Williams Jr.

  • Hoshedar Tamboli

  • Thomas Christen

  • Dominic Allocco

  • Ian Meredith

Medical Centers

  • North Florida Regional Medical Center, Gainesville, Florida, United States

  • CoxHealth, Springfield, Missouri, United States

  • Novant Health Heart and Vascular Institute at Presbyterian Medical Center, Charlotte, North Carolina, United States

  • Texas Heart and Vascular, Austin, Texas, United States

  • Huntsville Hospital Heart Center, Huntsville, Alabama, United States

  • Piedmont Heart Institute, Atlanta, Georgia, United States

  • Bay Area Cardiology and Vascular, Brandon, Florida, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved